Platelet count and parameters determined by the Bayer ADVIA™ 120 in reference subjects and patients

被引：47

作者：

Giacomini, A

Legovini, P

Gessoni, G

Antico, F

Valverde, S

Salvadego, MM

Manoni, F

机构：

[1] Chioggia Hosp, Dept Clin Pathol, Venice, Italy

[2] Univ Padua, Dept Pure & Appl Math, Padua, Italy

来源：

CLINICAL AND LABORATORY HAEMATOLOGY | 2001年 / 23卷 / 03期

关键词：

platelets; mean platelet component; reference range; ADVIA (TM) 120 System; thrombocytopenia;

D O I：

10.1046/j.1365-2257.2001.00391.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In order to study the behaviour of traditional and new platelet parameters determined by the ADVIA(TM) 120 Hematology System, five hundred samples from reference subjects, divided for sex and age, were processed. Significant variations on the basis of sex and age were found. Reference ranges as 95% confidence limits were therefore calculated for each age class, and platelet parameters proved to have specific variations during lifetime. Moreover, one hundred samples from thrombocytopenic patients were processed by the ADVIA(TM) 120 System. When compared with those of reference subjects matched for sex and age, all platelet parameters, except mean platelet component (MPC), showed significant differences.

引用

页码：181 / 186

页数：6

共 30 条

[1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[2] Platelets in glomerular disease [J].

Barnes, JL .

NEPHRON, 1997, 77 (04) :378-393

[3]

BESSMAN JD, 1981, AM J CLIN PATHOL, V76, P289

[4]

BLEKER OP, 1999, AM J OBSTET GYNECOL, V177, P434

[5] The determination of a reference range for new platelet parameters produced by the Bayer ADVIA™ 120 full blood count analyser [J].

Brummitt, DR ;

Barker, HF .

CLINICAL AND LABORATORY HAEMATOLOGY, 2000, 22 (02) :103-107

[6] Platelet surface activation antigen expression at baseline and during elective angioplasty in patients with mild to moderate coronary artery disease [J].

Cahill, MR ;

Macey, MG ;

Dawson, JR ;

Newland, AC .

BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (02) :165-168

[7] Correlation of GP53 and P-selectin expression in myeloproliferative disorders and normal controls [J].

Cahill, MR ;

Macey, MG ;

Newland, AC .

BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (02) :169-171

[8]

Chapman ES, 1996, BLOOD, V88, P2929

[9] PLATELETS CIRCULATE IN AN ACTIVATED STATE IN INFLAMMATORY BOWEL-DISEASE [J].

COLLINS, CE ;

CAHILL, MR ;

NEWLAND, AC ;

RAMPTON, DS .

GASTROENTEROLOGY, 1994, 106 (04) :840-845

[10] Moderate and advanced Alzheimer's patients exhibit platelet activation differences [J].

Davies, TA ;

Long, HJ ;

Tibbles, HE ;

Sgro, KR ;

Wells, JM ;

Rathbun, WH ;

Seetoo, KF ;

McMenamin, ME ;

Smith, SJ ;

Feldman, RG ;

Levesque, CA ;

Fine, RE ;

Simons, ER .

NEUROBIOLOGY OF AGING, 1997, 18 (02) :155-162

← 1 2 3 →